S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   202.41 (+3.02%)
AAPL   271.10 (+3.29%)
FB   168.83 (+1.98%)
MSFT   169.60 (+2.62%)
GOOGL   1,217.01 (+2.86%)
AMZN   2,011.60 (+0.70%)
CGC   14.48 (+0.98%)
NVDA   259.03 (-3.49%)
BABA   199.99 (+1.80%)
MU   46.54 (+0.37%)
GE   7.02 (-2.90%)
TSLA   545.45 (+5.66%)
AMD   49.02 (+3.16%)
T   30.38 (+3.19%)
F   4.71 (+3.97%)
NFLX   380.15 (+0.05%)
BAC   22.82 (+6.69%)
GILD   74.67 (-3.94%)
DIS   104.95 (+5.39%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   202.41 (+3.02%)
AAPL   271.10 (+3.29%)
FB   168.83 (+1.98%)
MSFT   169.60 (+2.62%)
GOOGL   1,217.01 (+2.86%)
AMZN   2,011.60 (+0.70%)
CGC   14.48 (+0.98%)
NVDA   259.03 (-3.49%)
BABA   199.99 (+1.80%)
MU   46.54 (+0.37%)
GE   7.02 (-2.90%)
TSLA   545.45 (+5.66%)
AMD   49.02 (+3.16%)
T   30.38 (+3.19%)
F   4.71 (+3.97%)
NFLX   380.15 (+0.05%)
BAC   22.82 (+6.69%)
GILD   74.67 (-3.94%)
DIS   104.95 (+5.39%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   202.41 (+3.02%)
AAPL   271.10 (+3.29%)
FB   168.83 (+1.98%)
MSFT   169.60 (+2.62%)
GOOGL   1,217.01 (+2.86%)
AMZN   2,011.60 (+0.70%)
CGC   14.48 (+0.98%)
NVDA   259.03 (-3.49%)
BABA   199.99 (+1.80%)
MU   46.54 (+0.37%)
GE   7.02 (-2.90%)
TSLA   545.45 (+5.66%)
AMD   49.02 (+3.16%)
T   30.38 (+3.19%)
F   4.71 (+3.97%)
NFLX   380.15 (+0.05%)
BAC   22.82 (+6.69%)
GILD   74.67 (-3.94%)
DIS   104.95 (+5.39%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   202.41 (+3.02%)
AAPL   271.10 (+3.29%)
FB   168.83 (+1.98%)
MSFT   169.60 (+2.62%)
GOOGL   1,217.01 (+2.86%)
AMZN   2,011.60 (+0.70%)
CGC   14.48 (+0.98%)
NVDA   259.03 (-3.49%)
BABA   199.99 (+1.80%)
MU   46.54 (+0.37%)
GE   7.02 (-2.90%)
TSLA   545.45 (+5.66%)
AMD   49.02 (+3.16%)
T   30.38 (+3.19%)
F   4.71 (+3.97%)
NFLX   380.15 (+0.05%)
BAC   22.82 (+6.69%)
GILD   74.67 (-3.94%)
DIS   104.95 (+5.39%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aptevo TherapeuticsCeaproMedicureGuardion Health SciencesUnum Therapeutics
SymbolNASDAQ:APVOOTCMKTS:CRPOFOTCMKTS:MCUJFNASDAQ:GHSINASDAQ:UMRX
Price Information
Current Price$3.34$0.15$1.24$0.45$0.33
52 Week RangeBuyN/AN/AN/AHold
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AHold
Consensus Price Target$2.35N/AN/AN/A$3.50
% Upside from Price Target-29.64% downsideN/AN/AN/A960.61% upside
Trade Information
Market Cap$10.50 million$11.25 million$13.39 million$36.63 million$9.80 million
Beta2.611.50.74N/A1.14
Average Volume154,2398,1651,5869,677,842305,634
Sales & Book Value
Annual Revenue$32.42 million$8.94 million$22.46 million$900,000.00$22.50 million
Price / Sales0.331.260.6042.160.45
CashflowN/AN/A$0.21 per shareN/AN/A
Price / CashN/AN/A5.91N/AN/A
Book Value$3.66 per share$0.23 per share$4.15 per share$0.16 per share$1.04 per share
Price / Book0.910.630.302.780.32
Profitability
Net Income$-40,450,000.00$-240,000.00$3.03 million$-10,880,000.00$-31,830,000.00
EPS($15.27)N/AN/AN/A($1.04)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-124.75%-6.22%-11.31%-1,204.87%-141.49%
Return on Equity (ROE)-184.48%-4.07%-3.55%-163.29%-85.21%
Return on Assets (ROA)-68.52%-3.40%-2.87%-138.18%-49.37%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.28%0.13%N/A0.04%0.14%
Current Ratio0.78%3.23%4.20%28.95%3.06%
Quick Ratio0.62%2.71%3.59%28.19%3.06%
Ownership Information
Institutional Ownership Percentage29.13%N/AN/A3.38%32.52%
Insider Ownership Percentage11.41%N/A12.90%8.47%31.30%
Miscellaneous
Employees118N/AN/A1956
Shares Outstanding3.23 million77.61 million10.80 million85.26 million30.61 million
Next Earnings Date5/14/2020 (Estimated)5/28/2020 (Estimated)5/25/2020 (Estimated)N/A5/11/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel